Vericel Corp Contracts & Agreements
179 Contracts & Agreements
- Business Finance (45 contracts)
- Business Formation (2)
- Business Operations (23)
- Human Resources (62)
- Intellectual Property (6)
- Real Estate (4)
- Uncategorized (37)
- Vericel Corporation Deferred Compensation Plan (Filed With SEC on August 2, 2023)
- Vericel Corporation 2022 Omnibus Incentive Plan Restricted Stock Unit Award (Deferred) Agreement for Non-Employee Directors (Filed With SEC on August 2, 2023)
- Vericel Corporation Deferred Compensation Plan (Filed With SEC on May 5, 2023)
- Eighth Amendment to the Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated May 15, 2022 (Filed With SEC on August 3, 2022)
- Third Amendment to the Dispensing Agreement between AllCare Plus Pharmacy, Inc. and the Company, dated May 16, 2022 (Filed With SEC on August 3, 2022)
- Form of New Hire Incentive Stock Option Agreement under the 2022 Omnibus Incentive Plan (Filed With SEC on August 3, 2022)
- Form of Current Employee Incentive Stock Option Agreement under the 2022 Omnibus Incentive Plan (Filed With SEC on August 3, 2022)
- Form of Restricted Stock Unit Award Agreement for Employees under the 2022 Omnibus Incentive Plan (Filed With SEC on August 3, 2022)
- Form of Restricted Stock Unit Award Agreement for Non-employee Directors under the 2022 Omnibus Incentive Plan (Filed With SEC on August 3, 2022)
- Form of Non-Qualified Stock Option Award Agreement for Non-Employee Directors under the 2022 Omnibus Incentive Plan (Filed With SEC on August 3, 2022)
- Lease Agreement, dated January 28, 2022, by and between the Company and NBD Property Owner 2, L.P (Filed With SEC on May 4, 2022)
- Form of Current Employee Incentive Stock Option Agreement under the 2019 Omnibus Incentive Plan (amended February 15, 2022) (Filed With SEC on May 4, 2022)
- Form of New Hire Incentive Stock Option Award Agreement under the 2019 Omnibus Incentive Plan (amended February 15, 2022) (Filed With SEC on May 4, 2022)
- Form of Non-Qualified Stock Option Award Agreement for Non-Employee Directors under the 2019 Omnibus Incentive Plan (amended February 15, 2022) (Filed With SEC on May 4, 2022)
- Vericel Corporation 2022 Omnibus Incentive Plan (Filed With SEC on April 29, 2022)
- Amendment 2 to Shareholder Rights Agreement, dated as of February 11, 2021 (Filed With SEC on February 24, 2021)
- Lease Agreement, dated October 21, 2020, by and between the Company and Up 64 Sidney Street, LLC, as amended (Filed With SEC on February 24, 2021)
- Form of Amended and Restated Incentive Stock Option Agreement for Employees under the 2019 Omnibus Incentive Plan (Filed With SEC on February 24, 2021)
- Form of Amended and Restated Incentive Stock Option Agreement for New Hires under the 2019 Omnibus Incentive Plan (Filed With SEC on February 24, 2021)
- Form of Amended and Restated Non-Qualified Stock Option Agreement under the 2019 Omnibus Incentive Plan (Filed With SEC on February 24, 2021)
- Form of Amended and Restated Restricted Stock Unit Award Agreement for Employees under the 2019 Omnibus Incentive Plan (Filed With SEC on February 24, 2021)
- Form of Restricted Stock Unit Award Agreement for Non-employee (Filed With SEC on February 24, 2021)
- Employment Agreement, dated (Filed With SEC on February 24, 2021)
- Employment Agreement, dated (Filed With SEC on February 24, 2021)
- Amendment No. 2 to Shareholder Rights Agreement, dated as of February 11, 2021, between the Company and Continental Stock Transfer & Trust Company, as Rights Agent (Filed With SEC on February 12, 2021)
- Employment Agreement, dated January 21, 2021, by and between Vericel Corporation and Joseph Mara (Filed With SEC on January 25, 2021)
- Vericel Corporation Amended and Restated 2019 Omnibus Incentive Plan (Filed With SEC on May 1, 2020)
- Description of Capital Stock (Filed With SEC on February 25, 2020)
- Sixth Amendment to Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated April 18, 2019 (Filed With SEC on August 6, 2019)
- First Amendment to Dispensing Agreement by and between AllCare Plus Pharmacy and the Company, dated May 1, 2019 (Filed With SEC on August 6, 2019)
- Supply Agreement between MediWound, Ltd. and the Company, dated May 6, 2019 (Filed With SEC on August 6, 2019)
- Amended and Restated Employment Agreement by and between Michael Halpin and the Company, dated September 14, 2017 (Filed With SEC on August 6, 2019)
- First Amendment to Employment Agreement by and between Michael Halpin and the Company, dated June 3, 2019 (Filed With SEC on August 6, 2019)
- License Agreement between MediWound, Ltd. and the Company, dated May 6, 2019 (Filed With SEC on August 6, 2019)
- Vericel Corporation 2019 Omnibus Incentive Plan (Filed With SEC on May 1, 2019)
- Form of Incentive Stock Option Agreement for Employees under the 2019 Omnibus Incentive Plan (Filed With SEC on May 1, 2019)
- Form of Incentive Stock Option Agreement for New Hires under the 2019 Omnibus Incentive Plan (Filed With SEC on May 1, 2019)
- Form of Non-Qualified Stock Option Agreement under the 2019 Omnibus Incentive Plan (Filed With SEC on May 1, 2019)
- Form of Restricted Stock Unit Award Agreement for Employees under the 2019 Omnibus Incentive Plan (Filed With SEC on May 1, 2019)
- Form of Restricted Stock Unit Award Agreement for non-employee directors under the 2019 Omnibus Incentive Plan (Filed With SEC on May 1, 2019)
- Form of New Hire Incentive Stock Option Agreement under the 2017 Omnibus Incentive Plan (Filed With SEC on February 26, 2019)
- Form of Incentive Stock Option Award Agreement under the 2017 Omnibus Incentive Plan (Filed With SEC on February 26, 2019)
- Form of Non-Employee Director Award Agreement under the 2017 Omnibus Incentive Plan (Filed With SEC on February 26, 2019)
- Form of Restricted Stock Unit Award Agreement under the 2017 Omnibus Incentive Plan (Filed With SEC on February 26, 2019)
- Fourth Amendment to Distribution Agreement between Orsini Pharmaceutical Services, Inc. and theCompany, dated July 25, 2018 (Filed With SEC on November 6, 2018)
- Dispensing Agreement by and between AllCare Plus Pharmacy and the Company, dated July 26, 2018 (Filed With SEC on November 6, 2018)
- Fifth Amendment to Distribution Agreement between Orsini Pharmaceutical Services, Inc. and theCompany, dated October 18, 2018 (Filed With SEC on November 6, 2018)
- Underwriting Agreement by and between Vericel Corporation and Leerink Partners LLC, as representative of the underwriters named therein, dated May 31, 2018 (Filed With SEC on June 1, 2018)
- Amended and Restated ACI-Maix Supply Agreement, dated March 17, 2018, as amended, by and between the Company and Matricel GMBH, incorporated herein by reference (Filed With SEC on May 8, 2018)
- Second Amendment to Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated October 13, 2017 (Filed With SEC on March 5, 2018)
- Third Amendment to Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated November 14, 2017 (Filed With SEC on March 5, 2018)
- Amended and Restated Non-employee Director Compensation Guidelines (Filed With SEC on March 5, 2018)
- Amendment No. 3 to License Agreement between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated October 9, 2017 (Filed With SEC on December 28, 2017)
- Amendment No. 3 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated October 9, 2017 (Filed With SEC on December 28, 2017)
- Amendment No. 4 to License Agreement between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated November 9, 2017 (Filed With SEC on December 28, 2017)
- Amendment No. 4 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated November 9, 2017 (Filed With SEC on December 28, 2017)
- Amendment No. 5 to License Agreement between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated December 5, 2017 (Filed With SEC on December 28, 2017)
- Amendment No. 5 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated December 5, 2017 (Filed With SEC on December 28, 2017)
- Warrant issued by the Company to ICT (Filed With SEC on December 28, 2017)
- Third Loan Modification Agreement, dated as of December 6, 2017, by and between the Company, Agent and Lenders (Filed With SEC on December 8, 2017)
- Form of Warrant issued by the Company to each of SVB and MidCap (Filed With SEC on December 8, 2017)
- Amendment No. 1 to License Agreement between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated August 3, 2017 (Filed With SEC on November 7, 2017)
- Amendment No. 2 to License Agreement between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated September 5, 2017 (Filed With SEC on November 7, 2017)
- Amendment No. 1 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated August 3, 1017 (Filed With SEC on November 7, 2017)
- Amendment No. 2 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated September 5, 2017 (Filed With SEC on November 7, 2017)
- First Amendment to Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated August 10, 2017 (Filed With SEC on November 7, 2017)
- First Amendment to Executive Employment Agreement by and between Dominick C. Colangelo and the Company, dated September 14, 2017 (Filed With SEC on September 19, 2017)
- Amended and Restated Employment Agreement by and between Daniel Orlando and the Company, dated September 14, 2017 (Filed With SEC on September 19, 2017)
- Amended and Restated Employment Agreement by and between Gerard Michel and the Company, dated September 15, 2017 (Filed With SEC on September 19, 2017)
- SECOND LOAN MODIFICATION AGREEMENT (Filed With SEC on June 2, 2017)
- * * * * * (Filed With SEC on June 2, 2017)
- DISTRIBUTION AGREEMENT (Filed With SEC on June 2, 2017)
- FIFTH AMENDMENT TO SERVICES AGREEMENT (Filed With SEC on June 2, 2017)
- WARRANT TO PURCHASE STOCK (Filed With SEC on May 15, 2017)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on December 30, 2016)
- CONFIDENTIAL AND PROPRIETARY TO PPD (Filed With SEC on December 30, 2016)
- FIRST LOAN MODIFICATION AGREEMENT (Filed With SEC on December 30, 2016)
- 6,200,000 Shares VERICEL CORPORATION Common Stock PURCHASE AGREEMENT (Filed With SEC on December 16, 2016)
- DISTRIBUTION AND SERVICES AGREEMENT (Filed With SEC on November 25, 2016)
- FOURTH AMENDMENT TO SERVICES AGREEMENT (Filed With SEC on November 25, 2016)
- THIRD AMENDMENT TO SERVICES AGREEMENT (Filed With SEC on November 7, 2016)
- VERICEL CORPORATION $25,000,000 COMMON STOCK SALES AGREEMENT (Filed With SEC on October 11, 2016)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on September 14, 2016)
- WARRANT TO PURCHASE STOCK (Filed With SEC on September 14, 2016)
- AMENDED AND RESTATED CONTRACT MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on August 8, 2016)
- FIRST AMENDMENT TO SERVICES AGREEMENT (Filed With SEC on August 8, 2016)
- SECOND AMENDMENT TO SERVICES AGREEMENT (Filed With SEC on August 8, 2016)
- SEVENTH AMENDMENT TO TRANSITION SERVICES AGREEMENT (Filed With SEC on August 8, 2016)
- SERVICES AGREEMENT (Filed With SEC on May 10, 2016)
- TRANSITION SERVICES AGREEMENT by and among GENZYME CORPORATION and AASTROM BIOSCIENCES,INC. Dated as of May30, 2014 TABLE OF CONTENTS (Filed With SEC on March 14, 2016)
- TRANSITION SUPPLY AGREEMENT (Filed With SEC on March 14, 2016)
- 64 Sidney Street Cambridge, Massachusetts LANDLORD FC 64 SIDNEY, INC. TENANT GENZYME CORPORATION TABLE OF CONTENTS (Filed With SEC on March 14, 2016)
- 64 Sidney Street Cambridge, Massachusetts LANDLORD FC 64 SIDNEY, INC. TENANT GENZYME CORPORATION Table of Contents (Filed With SEC on March 14, 2016)
- THIRD AMENDMENT TO A LEASE AGREEMENT BETWEEN DOMINOS FARMS OFFICE PARK, L.L.C. (LANDLORD) AND AASTROM BIOSCIENCES, INC. (TENANT) (Filed With SEC on March 14, 2016)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on March 9, 2016)
- SECURITIES EXCHANGE AGREEMENT (Filed With SEC on December 18, 2015)
- ACI-MAIX SUPPLY AGREEMENT between (Filed With SEC on November 13, 2015)
- Nonemployee Director Compensation Guidelines (Filed With SEC on March 25, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on November 12, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 1, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 1, 2014)
- UNDERWRITING AGREEMENT between AASTROM BIOSCIENCES, INC. and LADENBURG THALMANN & CO. INC. as Representative of the Several Underwriters (Filed With SEC on September 8, 2014)
- Employment Offer Letter (Filed With SEC on June 4, 2014)
- TRANSITION SERVICES AGREEMENT by and among GENZYME CORPORATION and AASTROM BIOSCIENCES, INC. Dated as of May 30, 2014 (Filed With SEC on June 2, 2014)
- TRANSITION SUPPLY AGREEMENT (Filed With SEC on June 2, 2014)
- Employment Offer Letter (Filed With SEC on April 1, 2014)
- Employment Offer Letter (Filed With SEC on April 1, 2014)
- PURCHASE AGREEMENT (Filed With SEC on January 27, 2014)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 27, 2014)
- CONSULTING SERVICES AGREEMENT (Filed With SEC on January 14, 2014)
- AMENDMENT NO. 1 TO AT MARKET ISSUANCE SALES AGREEMENT (Filed With SEC on November 29, 2013)
- UNDERWRITING AGREEMENT between AASTROM BIOSCIENCES, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on August 13, 2013)
- [FORM OF WARRANT] AASTROM BIOSCIENCES, INC WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 13, 2013)
- UNDERWRITING AGREEMENT between AASTROM BIOSCIENCES, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on August 12, 2013)
- [FORM OF WARRANT] AASTROM BIOSCIENCES, INC WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 12, 2013)
- UNDERWRITING AGREEMENT between AASTROM BIOSCIENCES, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on July 25, 2013)
- [] Shares Aastrom Biosciences, Inc. Common Stock (no par value) Underwriting Agreement dated [], 2013 (Filed With SEC on May 13, 2013)
- STANDARD LEASE SUMMARY (Filed With SEC on April 9, 2013)
- EMPLOYMENT AGREEMENT (Filed With SEC on April 9, 2013)
- MASTER SERVICES AGREEMENT (Filed With SEC on March 18, 2013)
- RESIGNATION AGREEMENT (Filed With SEC on March 18, 2013)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 8, 2013)
- Employment Offer Letter (Filed With SEC on December 12, 2012)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 26, 2012)
- SECOND AMENDMENT TO AASTROM BIOSCIENCES, INC. 2009 OMNIBUS INCENTIVE PLAN (Filed With SEC on August 7, 2012)
- FORM OF WARRANT EXCHANGE AGREEMENT (Filed With SEC on June 27, 2012)
- AMENDMENT NO. 1 TO SHAREHOLDER RIGHTS AGREEMENT (Filed With SEC on March 9, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 9, 2012)
- AASTROM BIOSCIENCES, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 9, 2012)
- MASTER SERVICES AGREEMENT (Filed With SEC on November 22, 2011)
- CONFIDENTIAL AND PROPRIETARY TO [ * * * ] (Filed With SEC on November 22, 2011)
- AASTROM BIOSCIENCES, INC. (Filed With SEC on June 16, 2011)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 25, 2011)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 25, 2011)
- AASTROM BIOSCIENCES, INC. SENIOR EXECUTIVE INCENTIVE BONUS PLAN (Filed With SEC on March 25, 2011)
- FIRST AMENDMENT TO AASTROM BIOSCIENCES, INC. 2009 OMNIBUS INCENTIVE PLAN (Filed With SEC on March 25, 2011)
- WARRANT AGREEMENT (Filed With SEC on December 16, 2010)
- Underwriting Agreement between the Company and Stifel, Nicolaus & Company, Incorporated, as representative of the Underwriters, dated as of December 10, 2010 (Filed With SEC on December 10, 2010)
- Underwriting Agreement between the Company and Stifel, Nicolaus & Company, Incorporated, as representative of the Underwriters, dated as of December 10, 2010 (Filed With SEC on December 10, 2010)
- AASTROM BIOSCIENCES, INC. (Filed With SEC on August 31, 2010)
- [COMPANY LETTERHEAD] EMPLOYMENT AGREEMENT (Filed With SEC on June 8, 2010)
- CLASS A WARRANT AGREEMENT (Filed With SEC on January 27, 2010)
- CLASS B WARRANT AGREEMENT (Filed With SEC on January 27, 2010)
- Aastrom Biosciences, Inc. 46,154,000 Shares of Common Stock Class A Warrants to Purchase 34,615,500 Shares of Common Stock Class B Warrants to Purchase 23,077,000 Shares of Common... (Filed With SEC on January 15, 2010)
- RESTATED ARTICLES OF INCORPORATION FOR USE BY DOMESTIC PROFIT CORPORATIONS (as amended in electronic format only as of December 14, 2009) (Filed With SEC on December 17, 2009)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on June 12, 2009)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 12, 2009)
- TERMINATION AGREEMENT (Filed With SEC on May 27, 2009)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on October 29, 2008)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 29, 2008)
- RESTATED ARTICLES OF INCORPORATION FOR USE BY DOMESTIC PROFIT CORPORATIONS (as restated in electronic format only as of October 17, 2008) (Filed With SEC on October 23, 2008)
- BYLAWS OF AASTROM BIOSCIENCES, INC. (Filed With SEC on October 23, 2008)
- CURRENT ASSETS (Filed With SEC on May 12, 2008)
- AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2008)
- ESCROW AGREEMENT (Filed With SEC on October 16, 2007)
- AGREED AND ACCEPTED: Name of Investor: Name Title: Address: DWAC Number: AASTROM BIOSCIENCES, INC. By: Name: Title: (Filed With SEC on October 16, 2007)
- Warrant No. [ ] Number of Shares: [ ] (subject to adjustment) Date of Issuance: October ___, 2007 Original Issue Date (as defined in subsection 2(a)): October ___, 2007 (Filed With SEC on October 16, 2007)
- CURRENT ASSETS (Filed With SEC on February 9, 2007)
- CURRENT ASSETS (Filed With SEC on February 9, 2006)
- CURRENT ASSETS (Filed With SEC on February 9, 2006)
- Local bone regeneration such as is needed in fractures, spinal fusion, and jaw bone reconstruction (Filed With SEC on September 13, 2005)
- Local bone regeneration such as is needed in fractures, spinal fusion, and jaw bone reconstruction (Filed With SEC on September 13, 2005)
- Local bone regeneration such as is needed in fractures, spinal fusion, and jaw bone reconstruction (Filed With SEC on September 13, 2005)
- Local bone regeneration such as is needed in fractures, spinal fusion, and jaw bone reconstruction (Filed With SEC on September 13, 2005)
- CURRENT ASSETS (Filed With SEC on November 9, 2004)
- CURRENT ASSETS (Filed With SEC on November 9, 2004)
- Local bone regeneration in fractures, spinal fusion and jaw bone reconstruction for dental implants (Filed With SEC on September 13, 2004)
- Engagement Agreement dated March 19, 2004 by and between the Company and Jesup & Lamont Securities Corporation (Filed With SEC on April 2, 2004)
- LEGAL PROCEEDINGS (Filed With SEC on September 9, 2003)
- LEGAL PROCEEDINGS (Filed With SEC on September 9, 2003)
- LEGAL PROCEEDINGS (Filed With SEC on September 9, 2003)
- LEGAL PROCEEDINGS (Filed With SEC on September 9, 2003)
- Common Stock Purchase Agreement with Fusion Capital Fund II, LLC dated October 20, 2002 (Filed With SEC on November 27, 2002)
- Common Stock Purchase Agreement with Fusion Capital Fund II, LLC dated October 20, 2002 (Filed With SEC on November 27, 2002)
- LEGAL PROCEEDINGS (Filed With SEC on September 30, 2002)
- LEGAL PROCEEDINGS (Filed With SEC on September 30, 2002)
- LEGAL PROCEEDINGS (Filed With SEC on September 30, 2002)
- EMPLOYMENT AGREEMENT (Filed With SEC on September 14, 2001)
- EMPLOYMENT AGREEMENT (Filed With SEC on September 14, 2001)